| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Wynne Sarah | Chief Financial Officer | 1350 EUCLID AVENUE, SUITE 1600, CLEVELAND | /s/ Rachel Quinlan as attorney in fact for Sarah Wynne | 2025-11-06 | 0001758252 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | TDG | Stock Option | Award | $0 | +8.7K | $0.00 | 8.7K | Nov 4, 2025 | Common Stock | 8.7K | $1,291.97 | Direct | F1 |
| Id | Content |
|---|---|
| F1 | These options are exercisable at 50% per year in 2029 and 50% in 2030 subject to the achievement of annual operating performance targets in each year. |